Insilico Medicine Receives FDA IND Approval for ISM8969, a Potential Best-in-Class AI-Empowered NLRP3 Inhibitor

U.S. Food and Drug Administration (FDA) approval of the Investigational New Drug (IND) application for ISM8969 clears the path for its clinical study in the United States. The Phase I clinical trial will assess safety, tolerability, and pharmacokinetic profiles. ISM8969 is a new oral therapeutic candidate created using Insilico’s Pharma.AI…

Iran’s Revolutionary Guard Commander Says Regime Has ‘Finger on the Trigger’ as U.S. Warships Head to Middle East

On Saturday, the leader of Iran’s Revolutionary Guard Corps (IRGC) issued a warning to the U.S., stating the paramilitary group is "more prepared than ever—finger on the trigger" as American warships deploy to the Middle East. This caution follows weeks of pressure from the President amid large-scale anti-regime demonstrations and…

NOW ACCEPTING REGISTRATIONS FOR CLARION SAFETY SYSTEMS’ FREE 2026 WEBINAR ON OPTIMIZING ON-PRODUCT WARNINGS

Live online event to explore symbol-based warnings, standards harmonization, and the role of warnings in modern equipment design MILFORD, Pa., Jan. 23, 2026 — Clarion Safety Systems has announced that registration is now open for its upcoming free, live webinar, Maximizing Your On-Product Warnings: Understanding Symbol-Based Warnings in Modern Equipment…

ZBD Announces $40M Series C to Integrate Real-Money Payments and Rewards Natively into Video Games

HOBOKEN, N.J., Jan. 22, 2026 — , the payments innovator enabling real-money transactions for games and applications, today revealed it has secured USD $40M in Series C financing commitments from Blockstream Capital Partners (“BCP”). This investment accelerates its growth as the only fully licensed, vertically integrated payments provider built exclusively…